Gymnemagenin
CAS No. 22467-07-8
Gymnemagenin( —— )
Catalog No. M20418 CAS No. 22467-07-8
Gymnemagenin is a potent and selective antagonist for the β isoform of LXR it has antihyperglycemic activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 295 | In Stock |
|
| 10MG | 444 | In Stock |
|
| 25MG | 710 | In Stock |
|
| 50MG | 963 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGymnemagenin
-
NoteResearch use only, not for human use.
-
Brief DescriptionGymnemagenin is a potent and selective antagonist for the β isoform of LXR it has antihyperglycemic activity.
-
DescriptionGymnemagenin is a potent and selective antagonist for the β isoform of LXR it has antihyperglycemic activity.
-
In Vitro——
-
In VivoGymnemagenin has a poor oral bioavailability (~ 14 %) in rats.Gymnemagenin has a short half-life and a high clearance in rats.Gymnemagenin metabolizes rapidly with a short apparent and intrinsic half-life (~ 7 min) and high intrinsic clearance.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorLXR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number22467-07-8
-
Formula Weight506.7
-
Molecular FormulaC30H50O6?
-
Purity>98% (HPLC)
-
SolubilityDMSO:30 mg/mL (59.2 mM)
-
SMILES[H][C@@]12CC(C)(C)[C@@H](O)[C@H](O)[C@]1(CO)[C@@H](O)C[C@]1(C)C2=CC[C@]2([H])[C@@]3(C)CC[C@H](O)[C@@](C)(CO)[C@]3([H])CC[C@@]12C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kang M H Lee M S Choi M K et al. Hypoglycemic Activity of Gymnema sylvestre Extracts on Oxidative Stress and Antioxidant Status in Diabetic Rats[J]. Journal of Agricultural and Food Chemistry 2012 60(10):2517-2524.
molnova catalog
related products
-
Steppogenin
Steppogenin exhibits significant tyrosinase inhibition activity, ;it also shows strong mushroom tyrosinase inhibitory activity with IC(50) values lower than 50 microM, more potent than kojic acid (IC(50) = 71.6 microM), a well-known tyrosinase inhibitor.
-
Somatostatin Tumor I...
Somatostatin Tumor Inhibiting Analog
-
Lixisenatide acetate
Lixisenatide acetate is a receptor agonist similar to glucagon-like peptide-1 (glp-1) for the treatment of type 2 diabetes mellitus (T2DM).
Cart
sales@molnova.com